Imagine going to the doctor, providing a quick blood sample, and finding out in minutes whether you might get diabetes… suffer a heart attack… or even develop cancer – years from now…
And then finding out how to prevent it. Today.
This process – known as Genomics – allows patients to have their entire genetic code analyzed so doctors can diagnose diseases before they even happen. And it’s quickly becoming the most important development in modern medicine.
As Forbes reported, “The cost of deciphering all six billion letters in the human genome has dropped from $1 million in 2007 to less than $20,000 today.”
And it’s getting cheaper by the day.
“Does this portent the beginning of a new kind of medicine?” asked Forbes Magazine. “Yes,” said Yale Medical School geneticist, Richard Lifton.
How to Play Genomics for Potential Triple-Bagger Gains:
Billionaire Randall Kirk, who made his riches in medicine, calls genomics “by far the best thing I have ever seen,” and “world changing.”
It’s no wonder this life-saving, fortune-creating science is already a $600-million market.
But that’s peanuts compared to the potential of this market – which could reach $100 BILLION in the next decade according to a recent Forbes research report.
And one small company is in the catbird seat.
More than 10,000 physicians in over 60 countries have already ordered more than 200,000 of its breast and colon cancer tests.
And get this: It’s just been announced that the Stage II colon cancer test will be covered by Medicare.
Right now this company’s trading at about $28, with a market cap of well under $1 billion. Yet my research shows it could rake in $250 million next year alone.
I believe these three companies alone could hand you 10 years worth of stock market gains in less than a year.
And so I’d like to share this research with you as soon as possible, first-hand.